NEW YORK (GenomeWeb News) – A panel formed by the US Centers for Disease Control and Prevention’s National Office of Public Health Genomics has said that it currently would not recommend cytochrome P450 gene testing with selective serotonin reuptake inhibitor drugs used for treating depression.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.